Stay updated with breaking news from Nasdaq Glpg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Galapagos NV (NASDAQ:GLPG – Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 1,500,000 shares, an increase of 5.6% from the March 31st total of 1,420,000 shares. Based on an average daily trading volume, of 124,300 shares, the short-interest ratio […]
Galapagos NV (NASDAQ:GLPG – Get Free Report)’s stock price hit a new 52-week low during trading on Wednesday . The company traded as low as $28.30 and last traded at $28.73, with a volume of 5527 shares changing hands. The stock had previously closed at $28.45. Wall Street Analyst Weigh In Several equities research analysts […]
Galapagos (NASDAQ:GLPG – Get Free Report) and Vivesto (OTCMKTS:OASMY – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends and analyst recommendations. Earnings & Valuation This table compares Galapagos and Vivesto’s […]
Bank of America reiterated their underperform rating on shares of Galapagos (NASDAQ:GLPG – Free Report) in a report released on Thursday, MarketBeat.com reports. The brokerage currently has a $31.00 price target on the biotechnology company’s stock, down from their prior price target of $41.00. Several other equities research analysts have also recently weighed in on […]
Galapagos (NASDAQ:GLPG – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Friday. Separately, Bank of America upped their price target on Galapagos from $41.00 to $44.00 and gave the company a “neutral” rating in a report on Tuesday. Seven […]